Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study
Public ClinicalTrials.gov record NCT02980848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Effectiveness of Breast Cancer Screening and Diagnostic Evaluation by Extent of Breast Density
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Breast Cancer Surveillance Consortium (BCSC) ADVANCE study is a large, observational pragmatic comparative effectiveness research study using high-quality, prospectively collected data from BCSC registries to generate evidence on how breast density should be integrated into decision making around breast cancer screening and preoperative diagnostic work-up. We will augment existing BCSC registry infrastructure with additional prospective data collection and collection of patient reported outcomes (PROs), CISNET modeling of long-term screening outcomes, and qualitative data from focus groups with women represented in two aims.
Study identification
- NCT ID
- NCT02980848
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,341,172 participants
Conditions and interventions
Conditions
Interventions
- Screening digital mammography Other
- Screening digital breast tomosynthesis Other
- Screening breast magnetic resonance imaging Other
- Diagnostic mammography Other
- Pre-operative breast magnetic resonance imaging Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 89 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Jan 31, 2022
- Completion
- Jan 31, 2022
- Last update posted
- Nov 16, 2021
2016 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sacramento Area Breast Imaging Registry | Davis | California | 95616 | — |
| San Francisco Mammography Registry | San Francisco | California | 94143 | — |
| Metro Chicago Breast Cancer Registry | Chicago | Illinois | 60607 | — |
| New Hampshire Mammography Network | Lebanon | New Hampshire | 03755 | — |
| Carolina Mammography Registry | Chapel Hill | North Carolina | 27599 | — |
| Vermont Breast Cancer Surveillance System | Burlington | Vermont | 05405 | — |
| Kaiser Permanente Washington Breast Cancer Surveillance Registry | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02980848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02980848 live on ClinicalTrials.gov.